Akoya Platform Picked by UK Consortium to Revolutionize Cancer Immunotherapy

 Consortium includes top universities, hospitals and industry partners, led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust

Akoya’s platforms will be used for deep spatial proteomic profiling of thousands of tissue samples from cancer patients to identify biomarkers predicting treatment success

https://www.globenewswire.com/news-release/2024/10/07/2958859/0/en/Akoya-s-Leading-Spatial-Proteomics-Platforms-Selected-for-Use-by-Ground-Breaking-UK-Based-MANIFEST-Consortium-to-Revolutionize-Cancer-Immunotherapy.html